Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
Saúde e medicinaOne-Off
Manifold MarketsFechadoSem KYCDados de resolução verificadosRazoavelmente calibradoEste mercado foi resolvido: Yes (93.8%)
Resolvido: 7 de out. de 2026, 19:39
Resolução verificada pelo provedor
A CoinRithm tem evidência do provedor para o vencedor e o horário de liquidação deste mercado.
Resultado Vencedor
Yes
A 7 dias
—
A 24 horas
—
Aviso de qualidade dos dadosDados desatualizados
Dados de 8 de out. de 2026, 09:36 UTC · política pm-quality-4
Linha do Tempo de Probabilidade
Yes93.8%
No6.200000000000003%
Ganhou
Perdeu
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRegras
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against any strain of influenza in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
